• HC Wainwright Reaffirms "Buy" Rating for Trevi Therapeutics (NASDAQ:TRVI)

    Source: Buzz FX / 20 Mar 2025 07:16:17   America/Chicago


    HC Wainwright Reaffirms "Buy" Rating for Trevi Therapeutics (NASDAQ:TRVI) Written by MarketBeat March 20, 2025 Share Link copied to clipboard. Remove Ads Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating res
    Read more...
Share on,